Literature DB >> 8955079

ATP synthase. Conditions under which all catalytic sites of the F1 moiety are kinetically equivalent in hydrolyzing ATP.

B D Reynafarje1, P L Pedersen.   

Abstract

Conditions have been reported under which the F1 moiety of bovine heart ATP synthase catalyzes the hydrolysis of ATP by an apparently cooperative mechanism in which the slow rate of hydrolysis at a single catalytic site (unisite catalysis) is enhanced more than 10(6)-fold when ATP is added in excess to occupy one or both of the other two catalytic sites (multisite catalysis) (Cross, R. L., Grubmeyer, C., and Penefsky, H. S. (1982) J. Biol. Chem. 257, 12101-12105). In the novel studies reported here, and in contrast to the earlier report, we have (a) monitored the kinetics of ATP hydrolysis of F1 by using nucleotide-depleted preparations and a highly sensitive chemiluminescent assay; (b) followed the reaction immediately upon addition of F1 to ATP, rather than after prior incubation with ATP; and (c) used a reaction medium with Pi as the only buffer. The following observations were noted. First, regardless of the source of enzyme, bovine or rat, and catalytic conditions (unisite or multisite), the rates of hydrolysis depend on ATP concentration to the first power. Second, the first order rate constant for ATP hydrolysis remains relatively constant under both unisite and multisite conditions declining only slightly at high ATP concentration. Third, the initial rates of ATP hydrolysis exhibit Michaelis-Menten kinetic behavior with a single Vmax exceeding 100 micromol of ATP hydrolyzed per min/mg of F1 (turnover number = 635 s-1) and a single Km for ATP of about 57 microM. Finally, the reaction is inhibited markedly by low concentrations of ADP. It is concluded that, under the conditions described here, all catalytic sites that participate in the hydrolysis of ATP within the F1 moiety of mitochondrial ATP synthase function in a kinetically equivalent manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955079     DOI: 10.1074/jbc.271.51.32546

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cooperativity between the enzymatic sites of F1-ATPase revisited by the use of HPLC methods.

Authors:  G Berger; G Girault; J L Zimmermann
Journal:  J Bioenerg Biomembr       Date:  1998-12       Impact factor: 2.945

2.  Bioenergetics of the heart at high altitude: environmental hypoxia imposes profound transformations on the myocardial process of ATP synthesis.

Authors:  Baltazar D Reynafarje; Emilio Marticorena
Journal:  J Bioenerg Biomembr       Date:  2002-12       Impact factor: 2.945

3.  Bi-site activation occurs with the native and nucleotide-depleted mitochondrial F1-ATPase.

Authors:  Y M Milgrom; M B Murataliev; P D Boyer
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  Comparison of different cations (Mn2+, Mg2+, Ca2+) on the hydrolytic activity of chloroplast ATPase.

Authors:  G Berger; G Girault
Journal:  J Bioenerg Biomembr       Date:  2001-04       Impact factor: 2.945

5.  Nucleotide and Mg2+ dependency of the thermal denaturation of mitochondrial F1-ATPase.

Authors:  J Villaverde; J Cladera; A Hartog; J Berden; E Padrós; M Duñach
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

6.  Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.

Authors:  Jean Philippe Annereau; Young Hee Ko; Peter L Pedersen
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

7.  Oxidative phosphorylation: kinetic and thermodynamic correlation between electron flow, proton translocation, oxygen consumption and ATP synthesis under close to in vivo concentrations of oxygen.

Authors:  Baltazar D Reynafarje; Jorge Ferreira
Journal:  Int J Med Sci       Date:  2008-06-09       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.